PlateletBio trails Sanofi among others in pursuit of a new therapy for a rare blood clotting disorder that has few treatments. But the biotech startup could stand apart from those drugs with its new class of cell therapy, which harnesses the properties of platelets.
Sanofi sees double-digit growth driven by megabrand Dupixent pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
Sanofi sees double-digit growth driven by megabrand Dupixent pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Deciduous Therapeutics, an early stage immune therapy start-up, announced today the appointment of an independent board member, additional.
/PRNewswire/ Deciduous Therapeutics, an early stage immune therapy start-up, announced today the appointment of an independent board member, additional.